Clinical Trial Update: A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects. [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial evaluating the efficacy of AD 452 in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AD 452

Snippet

Sponsor: Sosei | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED